TOKYO, March 01, 2026 — OrganTech, Inc. announced that its research team has identified the minimum set of stem cells needed to regenerate functional hair follicles in a laboratory setting, creating a clear cellular framework that could guide future regenerative treatments for hair loss and similar conditions.
The research, published in Biochemical and Biophysical Research Communications, further confirms OrganTech’s platform for regenerating entire organs, which is based on the biological interactions between epithelial and mesenchymal tissues.
Mouse hair follicles regenerated in the laboratory
A research team led by Koh-ei Toyoshima (General Manager of R&D at OrganTech, Inc.), Miho Ogawa (Director and CTO at OrganTech, Inc.), and Takashi Tsuji (formerly Team Leader of the Organ Induction Research Team at RIKEN Center for Biosystems Dynamics Research) discovered a previously unknown accessory mesenchymal cell type—named hair follicle regeneration-supporting cells—that is crucial for regenerating functional follicles in controlled laboratory conditions.
In the study, the researchers developed a controlled culture system to reconstruct hair follicles. They combined adult hair follicle-derived epithelial stem cells with dermal papilla cells to create follicle organ germs. Although these structures developed hair bulbs, they needed an additional accessory mesenchymal cell population to maintain downward growth and produce hair shafts.
By adding the newly identified supporting cells, the team created organ germs from three types of stem cells that could regenerate fully functional hair follicles under specific laboratory conditions. The reconstructed follicles showed hair bulb formation, continuous downward growth, and hair shaft production, indicating they function through hair cycles.
Unlike existing drug treatments like minoxidil or finasteride that mainly slow down hair loss, OrganTech’s method aims to rebuild complete, functional hair follicle units at the organ level using a precisely defined cellular structure.
Hair loss impacts tens of millions of people globally and presents a major growing market opportunity. The worldwide hair restoration market is expected to surpass $15 billion in the next ten years, showing increasing demand for long-lasting, biologically-based treatments.
“This research establishes a fundamental cellular blueprint for regenerating functional hair follicles,” stated Yoshio Shimo, Representative Director and CEO of OrganTech. “Beyond just hair biology, it supports our larger vision of organ-level regenerative medicine, where carefully coordinated interactions between epithelial and mesenchymal cells allow for stable, functional tissue reconstruction.”
The research enhances knowledge of hair follicle development, regeneration, and hair cycle control while offering a clear cellular roadmap for future clinical applications. More generally, it highlights an important principle in 3D organ regeneration: achieving mature organs may require additional accessory cell types beyond the standard epithelial-mesenchymal cell combinations.
OrganTech has submitted international patent applications for its organ germ-based regenerative technologies and is progressing with a step-by-step clinical development plan focused on hair loss and related regenerative applications.
Publication Information
Title
Fully Functional Hair Follicle Organ Regeneration Using Organ-Inductive Potential Stem Cells with an Accessory Mesenchymal Cell Population in an In Vitro Culture System
Authors
Koh-ei Toyoshima, Ayako Tsuchiya, Miho Ogawa, Miki Takase, Tarou Irié, Masayuki Yanagisawa, Richard H. Kaszynski, Hiroshi Fujimaki, Kyoko Baba, Takayuki Sugimoto, Akira Takeda, Akio Sato, and Takashi Tsuji
Journal
Biochemical and Biophysical Research Communications
DOI
10.1016/j.bbrc.2026.153459
About OrganTech, Inc.
OrganTech is a regenerative medicine company built on the organ germ method, a technology platform that originated from groundbreaking research on organ development driven by epithelial-mesenchymal interactions. The company is developing next-generation bioengineered organ technologies, including hair follicle regeneration, dental bio-hybrid implants, and 3D artificial skin systems. OrganTech seeks to create scalable, organ-level regenerative therapies that address major unmet medical needs around the world.
Contact Information
OrganTech, Inc.
Email: info@organ-tech.jp
